Galera Therapeutics News and Activities
Presence
Headquarters: United States (USA)
Galera Therapeutics is a company listed under the stock ticker GRTX (US).
Acquisition, funding and merger involving Galera Therapeutics.
- Galera Therapeutics and Obsidian Therapeutics have announced they will merge (posted on April 15 2026)..
Executives
View the org chart displaying its 6 main executives
Most searched biographies at Galera Therapeutics
- Mel Sorensen, Director, President and Chief Executive Officer
- Kevin Lokay, Director
- Nancy Chang, Director
Popular executive movements at Galera Therapeutics
- Jennifer Evans Stacey, Chief Legal and Compliance Officer, has left the company (posted on April 8 2026).
Create your alert
to follow the executive moves at Galera Therapeutics.
Biotechnology
Galera Therapeutics has 2,406 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and BioNTech (Germany).
Popular M&A news in Biotechnology
- Laboratoire Servier has announced the acquisition of Edgewise Therapeutics (posted on June 4 2026).
- Oak Hill Bio has just announced a $33 Million fundraising (posted on June 4 2026).
- IMU Biosciences has just announced a $53 Million fundraising (posted on June 3 2026).
Popular contacts in Biotechnology
News
Press releases by Galera Therapeutics
- Galera Therapeutics to Host Virtual KOL Event on the Treatment of Locally Advanced Pancreatic Cancer | Galera Therapeutics
- Galera Therapeutics Announces Dosing of First Patient in a Randomized, Double-Blind Pilot Phase 2 Clinical Trial of GC4419 for COVID-19 | Galera Therapeutics
- Galera Therapeutics to Present at the Oppenheimer Fall Healthcare Life Sciences & MedTech Summit | Galera Therapeutics
- Galera Therapeutics Announces ASTRO Late-Breaker Presentation of Topline Safety and Efficacy Data from its Double-Blind, Placebo-Controlled Phase 1b/2a Clinical Trial of GC4419 in Combination with SBRT for Locally Advanced Pancreatic Cancer | Galera Thera
- Galera Therapeutics Reports Second Quarter 2020 Financial Results and Provides Business Updates | Galera Therapeutics
- News Releases | Galera Therapeutics
- Galera Therapeutics to Participate in Fireside Chat at 2020 BTIG Virtual Biotechnology Conference | Galera Therapeutics
- Galera Therapeutics Completes Enrollment of Phase 1b/2a Clinical Trial of GC4419 in Combination with Radiotherapy for Locally Advanced Pancreatic Cancer | Galera Therapeutics
- Galera Therapeutics Announces Avasopasem Manganese Improved Markers of Chronic Kidney Disease in Patients Receiving Cisplatin | Galera Therapeutics
- Galera Therapeutics to Host Virtual KOL Event on Cisplatin-Induced Chronic Kidney Disease | Galera Therapeutics
- View more press releases Close
Social media about Galera Therapeutics
- Galera Therapeutics on Wikipedia, Google News & Yahoo Finance
- Galera Therapeutics on LinkedIn, X (Twitter) & YouTube
